BRIEF published on 05/11/2026 at 11:15, 3 months 15 days ago Schloss Wachenheim AG: Third Quarter Results and Updated Forecast Financial Results Buy Recommendation Schloss Wachenheim AG Geopolitical Impact Market Forecast
PRESS RELEASE published on 05/11/2026 at 11:10, 3 months 15 days ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Schloss Wachenheim AG (ISIN: DE0007229007) research with a Buy recommendation and reduced target price to EUR 18, reflecting weaker Q3 25/26 results First Berlin Equity Research Buy Recommendation Research Update Target Price Schloss Wachenheim AG
BRIEF published on 02/25/2026 at 13:51, 6 months 1 day ago Schloss Wachenheim AG: Buy Recommendation Reaffirmed Financial Results Buy Recommendation Target Price Schloss Wachenheim AG Consumer Sentiment
PRESS RELEASE published on 02/25/2026 at 13:46, 6 months 1 day ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Schloss Wachenheim AG with a BUY recommendation and revised target price of €19 based on Q2 25/26 results. EBIT rose 1.4% to €21.9m First Berlin Equity Research Buy Recommendation Schloss Wachenheim AG Q2 25/26 Results €19 Target Price
BRIEF published on 11/10/2025 at 13:17, 9 months 16 days ago Schloss Wachenheim AG: Positive Outlook with Increased Price Target Schloss Wachenheim AG Price Target Increase Q1 2025/26 Results France Segment Recovery Bond Yield Impacts
PRESS RELEASE published on 11/10/2025 at 13:12, 9 months 16 days ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research upgrades Schloss Wachenheim AG, recommends Buy with target price of €20 after strong Q1 25/26 results. Sales up 3.5% to €106.0m First Berlin Equity Research Buy Recommendation Schloss Wachenheim AG Q1 25/26 Results €20 Target Price
BRIEF published on 09/30/2025 at 11:03, 10 months 26 days ago Schloss Wachenheim AG: Buy Rating Reiterated Despite Challenges Financial Results Buy Recommendation Sales Growth Schloss Wachenheim Market Forecast
PRESS RELEASE published on 09/30/2025 at 10:58, 10 months 26 days ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Schloss Wachenheim AG analysis post-2024/25 Annual report, maintains BUY rating, lowers price target to €19 First Berlin Equity Research BUY Rating Analysis Price Target Schloss Wachenheim AG
BRIEF published on 05/12/2025 at 13:11, 1 year 3 months ago Schloss Wachenheim AG: Sales Decline but Optimism for Q4 Financial Performance Buy Recommendation Sales Decline Schloss Wachenheim AG Q4 Rebound
PRESS RELEASE published on 05/12/2025 at 13:06, 1 year 3 months ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research GmbH releases a research update on Schloss Wachenheim AG, maintaining a Buy recommendation with a lowered price target of €21 from €22 First Berlin Equity Research Buy Recommendation Price Target Schloss Wachenheim AG Q3 24/25 Results
Published on 08/26/2026 at 17:40, 1 hour ago Camino Closes $5.8 Million Brokered Private Placement of Units and Concurrent $9.4 Million Non-Brokered Private Placement of Convertible Debentures
Published on 08/26/2026 at 15:25, 3 hours 15 minutes ago CF Energy Announces Financial Results for the Three-Month and Six-Month Periods Ended June 30, 2026
Published on 08/26/2026 at 15:00, 3 hours 40 minutes ago Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 08/26/2026 at 15:00, 3 hours 40 minutes ago Arcus Announces Voting Results of the Annual General and Special Meeting
Published on 08/26/2026 at 14:30, 4 hours 10 minutes ago Klondike Gold Reports Additional Montana Creek Royalty Gold Receipts, Announces Phase 2 2026 Drill Program and Provides Exploration Update
Published on 08/26/2026 at 18:30, 10 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 40 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 17:45, 55 minutes ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 31 July 2026.
Published on 08/26/2026 at 17:15, 1 hour 24 minutes ago PANASONIC TOUGHBOOK CELEBRATES 30 YEARS OF FRONTLINE INNOVATION FOR MOBILE TEAMS
Published on 08/26/2026 at 16:55, 1 hour 44 minutes ago Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations
Published on 08/26/2026 at 18:02, 38 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 40 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
